In vivo evidence further highlighted the importance of glycolysis in UBR7 deficiency-induced tumor growth as glycolysis inhibitors completely abolished the promoting effect elicited by silencing UBR7 (Supplementary Fig. 12F). This evidence concerns the gene UBR7 and neoplasm.